'Am I Eating Okay?' — What ADA 2026 Says About Nutrition on GLP-1s

"Am I Eating Okay?" — The Question Every GLP-1 Patient Asks

At the American Diabetes Association 2026 Scientific Sessions in New Orleans, nutrition expert Patti Urbanski presented a case that resonated with every clinician in the room. Her patient, Brad — a 61-year-old newspaper editor with hypertension, hyperlipidemia, and prediabetes — came in six weeks after starting semaglutide. He had already lost 5.6 kg (about 12 pounds). His question was disarmingly simple: "My appetite and things have really changed, and I'm thinking maybe I need to check in. Am I doing okay?"

The answer is more complex than most patients — or prescribers — realize. GLP-1 medications fundamentally alter appetite, portion size, food preferences, and nutrient absorption patterns. A standard dietary handout is no longer sufficient. The ADA's 2026 Nutrition Consensus Statement reflects this new reality.

How GLP-1s Change Your Relationship with Food

Understanding these mechanisms helps explain why nutrition on GLP-1 therapy requires specific attention:

• Appetite suppression. GLP-1s act on hypothalamic appetite centers, reducing hunger signals. Patients frequently report going hours without thinking about food — a novel experience for many with obesity.
• Reduced portion size. Delayed gastric emptying means smaller meals feel satisfying. Patients who previously consumed 2,000-3,000 calories per day may naturally drop to 1,000-1,500 without conscious restriction.
• Altered food preferences. Many patients report reduced desire for high-fat, high-sugar foods. Some develop aversions to foods they previously enjoyed. These changes appear to involve GLP-1 receptor activity in brain reward pathways.
• Potential nutrient gaps. When total food intake drops significantly, the risk of inadequate protein, vitamins, and minerals increases — even if the foods consumed are generally healthy.

The ADA 2026 Nutrition Framework for GLP-1 Patients

Urbanski's presentation outlined a practical clinical framework that goes beyond general dietary advice. The core principles:

1. Protein First, Every Meal

With reduced appetite and smaller portions, protein must be prioritized deliberately. The recommendation: 1.0-1.2 grams per kilogram of body weight per day, distributed across all meals. For a 200-pound patient, that is approximately 90-110 grams daily.

This is harder than it sounds when your appetite is suppressed. Practical strategies include starting every meal with the protein component, choosing protein-dense foods (Greek yogurt, eggs, lean meats, legumes), and considering protein supplementation if whole-food intake falls short.

2. Fiber and Vegetables as the Second Priority

After protein, fill remaining capacity with fiber-rich vegetables and whole foods. Fiber supports gut health, provides micronutrients, and helps manage the constipation that is common with GLP-1 therapy. Aim for 25-30 grams of fiber daily.

3. Hydration Is Non-Negotiable

Reduced food intake means reduced water intake from food. Many GLP-1 patients become mildly dehydrated without realizing it, which can worsen constipation, fatigue, and headaches. Target at least 64 ounces of water daily, more if you are active or in warm climates.

4. Micronutrient Monitoring

Extended caloric restriction — even when medically supervised — can deplete specific nutrients. The ADA framework recommends periodic monitoring of vitamin B12 (GLP-1 medications may affect absorption), vitamin D, iron, calcium, and folate. A basic multivitamin can help bridge gaps, but targeted supplementation based on lab results is preferable.

Meal Timing on GLP-1 Therapy

Timing considerations depend on your specific medication:

• Injectable semaglutide or tirzepatide: No meal timing restrictions related to the injection. Focus on consistent meal patterns to maintain protein intake.
• Oral semaglutide (Wegovy pill): Must be taken on an empty stomach with no more than 4 oz of water, then wait 30 minutes before eating. This creates a morning routine that needs planning.
• Orforglipron: No food or water restrictions. Can be taken at any time, with or without meals.

Regardless of medication type, eating at regular intervals helps prevent the pattern many GLP-1 patients fall into: skipping meals because they are not hungry, then consuming too little total nutrition by day's end.

When to Request a Registered Dietitian Referral

Not every GLP-1 patient needs specialized nutrition counseling, but several situations warrant a referral:

• You are losing weight faster than expected (more than 1% of body weight per week after the initial month)
• You consistently consume fewer than 1,200 calories per day
• You have a history of disordered eating
• You are experiencing hair loss, fatigue, or muscle weakness
• You are over 65 years old (higher protein needs, greater sarcopenia risk)
• You have kidney disease or other conditions requiring dietary management

Many telehealth GLP-1 providers now include dietitian consultations as part of their programs. Ask your provider whether this is available.